Coopted temporal patterning governs cellular hierarchy, heterogeneity and metabolism in


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
30 09 2019
Historique:
received: 24 07 2019
accepted: 29 09 2019
pubmed: 1 10 2019
medline: 20 2 2020
entrez: 1 10 2019
Statut: epublish

Résumé

It is still unclear what drives progression of childhood tumors. During

Identifiants

pubmed: 31566561
doi: 10.7554/eLife.50375
pii: 50375
pmc: PMC6791719
doi:
pii:

Banques de données

GEO
['GSE114986', 'GSE114562']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondation ARC pour la Recherche sur le Cancer
ID : PJA20141201621
Pays : International
Organisme : Fondation ARC pour la Recherche sur le Cancer
ID : Fin de thèse
Pays : International
Organisme : Canceropôle PACA
ID : Starting Package Single Cell
Pays : International
Organisme : Aix-Marseille Université
ID : Bio trail
Pays : International
Organisme : Ligue Contre le Cancer
ID : Comprendre les principes fondamentaux régissant la hiérarchie cellulaire dans les tumeurs neurales
Pays : International

Informations de copyright

© 2019, Genovese et al.

Déclaration de conflit d'intérêts

SG, RC, CG, FB, KN, FD, SF, NL, CM No competing interests declared

Références

Methods Mol Biol. 2016;1478:227-239
pubmed: 27730585
Nature. 2019 Aug;572(7767):67-73
pubmed: 31043743
Oncogene. 2016 Sep 22;35(38):5000-9
pubmed: 26923328
Nature. 2013 Jun 27;498(7455):456-62
pubmed: 23783517
Cancer Cell. 2018 Feb 12;33(2):164-172
pubmed: 29438693
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Genes Dev. 2019 May 1;33(9-10):511-523
pubmed: 30862661
Development. 2012 Dec 1;139(23):4297-310
pubmed: 23132240
Nat Rev Cancer. 2005 Jun;5(6):481-8
pubmed: 15905853
Cell. 2006 Mar 24;124(6):1241-53
pubmed: 16564014
Cell. 2014 Aug 14;158(4):874-888
pubmed: 25126791
Curr Biol. 2017 May 8;27(9):1303-1313
pubmed: 28434858
Genome Biol. 2014;15(12):550
pubmed: 25516281
Oncogene. 2007 Aug 9;26(36):5184-93
pubmed: 17310982
Cell Rep. 2016 May 24;15(8):1634-47
pubmed: 27184842
Cell. 2011 Aug 5;146(3):435-47
pubmed: 21816278
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Dev Cell. 2006 Dec;11(6):775-89
pubmed: 17141154
Nat Methods. 2009 Aug;6(8):603-5
pubmed: 19633663
Curr Biol. 2014 Mar 31;24(7):793-800
pubmed: 24656828
Nucleic Acids Res. 2013 May 1;41(10):e108
pubmed: 23558742
Nat Methods. 2017 Mar;14(3):309-315
pubmed: 28114287
Nat Methods. 2017 Oct;14(10):979-982
pubmed: 28825705
Cell. 2014 Mar 13;156(6):1259-1273
pubmed: 24630726
Cancer Manag Res. 2016 Sep 16;8:115-125
pubmed: 27695363
Genes Dev. 2016 Nov 15;30(22):2459-2474
pubmed: 27940961
Nat Genet. 2005 Oct;37(10):1125-9
pubmed: 16142234
Science. 2019 May 10;364(6440):
pubmed: 31073041
Elife. 2017 Apr 10;6:
pubmed: 28394252
Annu Rev Pathol. 2016 May 23;11:47-76
pubmed: 27193450
Elife. 2016 Jun 14;5:
pubmed: 27296804
Elife. 2017 Jul 28;6:
pubmed: 28753127
Biochem Biophys Res Commun. 1992 Feb 14;182(3):1326-32
pubmed: 1540176
Development. 2006 Jul;133(14):2639-48
pubmed: 16774999
Dev Biol. 2000 Oct 1;226(1):34-44
pubmed: 10993672
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
Nature. 2013 Jun 27;498(7455):449-55
pubmed: 23783519
Nat Rev Cancer. 2012 Jan 12;12(2):133-43
pubmed: 22237392
Nature. 2011 Mar 24;471(7339):508-12
pubmed: 21346761
Development. 2002 Dec;129(24):5667-81
pubmed: 12421707
Neuro Oncol. 2009 Aug;11(4):403-13
pubmed: 19033157
Elife. 2014 Mar 11;3:e01906
pubmed: 24618901
Elife. 2014 Jun 04;3:null
pubmed: 24898756
Cell. 2010 Dec 23;143(7):1161-73
pubmed: 21183078
J Comp Neurol. 2011 Jun 15;519(9):1748-69
pubmed: 21452233
Dev Biol. 1988 Jan;125(1):145-57
pubmed: 3119399
IEEE Trans Pattern Anal Mach Intell. 2017 Nov;39(11):2227-2241
pubmed: 28114001
Genes Dev. 2012 Sep 1;26(17):1926-44
pubmed: 22899010
Development. 2017 Oct 1;144(19):3454-3464
pubmed: 28851709
Science. 2015 Oct 16;350(6258):317-20
pubmed: 26472907
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Br J Cancer. 2016 Jun 14;114(12):1305-12
pubmed: 27219018
Cell. 2001 Aug 24;106(4):511-21
pubmed: 11525736
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
Cell. 2006 Oct 20;127(2):409-22
pubmed: 17055440
Genes Dev. 2015 Jan 15;29(2):129-43
pubmed: 25593306
Dev Cell. 2018 Sep 24;46(6):807
pubmed: 30253171
Cell. 2008 May 30;133(5):891-902
pubmed: 18510932
Neuron. 2019 Jun 19;102(6):1111-1126.e5
pubmed: 31128945
Trends Neurosci. 2005 Jan;28(1):30-6
pubmed: 15626494
Dev Cell. 2006 Apr;10(4):441-9
pubmed: 16549393
Nature. 1995 Oct 19;377(6550):627-30
pubmed: 7566173
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13003-13008
pubmed: 27799520
Nat Rev Cancer. 2012 Nov;12(11):767-75
pubmed: 23051844
Nat Methods. 2011 Mar;8(3):260-6
pubmed: 21297619
Nat Rev Cancer. 2014 Apr;14(4):277-89
pubmed: 24599217
J Clin Oncol. 2015 Apr 10;33(11):1285-93
pubmed: 25753434
Development. 2018 Jan 25;145(2):
pubmed: 29361557

Auteurs

Sara Genovese (S)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Raphaël Clément (R)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Cassandra Gaultier (C)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Florence Besse (F)

Université Côte d'Azur, CNRS, Inserm, Institut de Biologie Valrose, Nice, France.

Karine Narbonne-Reveau (K)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Fabrice Daian (F)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Sophie Foppolo (S)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Nuno Miguel Luis (NM)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Cédric Maurange (C)

Aix Marseille Univ, CNRS, IBDM, Equipe Labellisée LIGUE Contre le Cancer, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH